Drugs induced Raynaud's phenomenon and underlying mechanism: a disproportionality analysis from the WHO pharmacovigilance database
database[Title] 2025-11-22
Summary:
CONCLUSION: This study allowed us to identify robust safety signals (such as solriamfetol, tyrosine kinase inhibitors and CGRP inhibitors) for drugs associated with RP and potential implicated pathophysiological mechanisms.